Oncotarget

Research Papers:

Targeting high Aurora kinases expression as an innovative therapy for hepatocellular carcinoma

Fuchen Liu, Guangyong Wang, Xiaoqiang Wang, Zhihui Che, Wei Dong, Xinggang Guo, Zhenguang Wang, Ping Chen, Daisen Hou, Qi Zhang, Wenli Zhang, Yida Pan, Dongqin Yang and Hui Liu _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:27953-27965. https://doi.org/10.18632/oncotarget.15853

Metrics: PDF 1344 views  |   HTML 1699 views  |   ?  


Abstract

Fuchen Liu1,2,*, Guangyong Wang3,*, Xiaoqiang Wang4,*, Zhihui Che2, Wei Dong1, Xinggang Guo1, Zhenguang Wang1, Ping Chen2, Daisen Hou2, Qi Zhang2, Wenli Zhang2, Yida Pan2, Dongqin Yang2, Hui Liu1

1The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China

2Department of Digestive Diseases of Huashan Hospital, Fudan University, Shanghai 200032, China

3Department of Gastroenterology, 411 Hospital of PLA, Shanghai 200081, China

4Department of Neurosurgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China

*These authors contributed equally to this work

Correspondence to:

Dongqin Yang, email: kobesakura@163.com

Hui Liu, email: liuhuigg@hotmail.com

Keywords: Aurora A/B kinases, SNS-314, HCC, YAP, P21

Received: November 18, 2016     Accepted: February 20, 2017     Published: March 02, 2017

ABSTRACT

The Aurora kinases A and B control tumorigenesis by inhibiting apoptosis and promoting proliferation and metastasis, however, it remains unknown whether Aurora A and B overexpressed concomitantly and its clinical significance in hepatocellular carcinoma (HCC). Here, we obsearved Aurora A and B tended to overexpress parallelly on protein level (r = 0.8679, P < 0.0001) and their co-overexpression (Aurora AHBH), associated with the worst prognosis, was an independent predictor for the survival. Importantly, with the lower IC50 and stronger anti-tumor effect than selective inhibitors, SNS-314, the pan-inhibitor of Aurora kinases, which induced YAP (Yes-associated protein) reduction and resulted in P21 accumulation, significantly promoted the polyploidy (> 4N) formation and apoptosis in HCC. High YAP expression (YAPH) was associated with Aurora AHBH, and appeared to be an independent predictor for survival, but P21 not. Moreover, silencing YAP also induced P21 accumulation, and knockdown P21, which enhanced YAP accumulation and weakened the SNS-314-induced YAP reduction, impaired SNS-314-induced apoptosis. Therefore, P21 enhanced the apoptotic effect of SNS-314 in HCC. Taken together, our findings indicated Aurora kinases/YAP/P21 was an oncogenic signaling axis in HCC, and revealed targeting Aurora AHBH induced apoptosis by YAP suppression. Our results also provided a solid evidence for SNS-314 as a potential targeted therapy, and a proof-of-concept evidence for a possible combined therapy of SNS-314 plus Hippo pathway inhibitors on HCC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 15853